STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)
CUSIP: 34385P108
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 384,731,503
- Total 13F shares
- 43,847,181
- Share change
- -6,138,280
- Total reported value
- $70,155,656
- Put/Call ratio
- 137%
- Price per share
- $1.60
- Number of holders
- 78
- Value change
- -$17,366,200
- Number of buys
- 39
- Number of sells
- 61
Quarterly Holders Quick Answers
What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34385P108:
Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Indaba Capital Management, L.P. |
13F
|
Company |
1.9%
|
7,446,229
|
$26,732,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
6,165,716
|
$22,135,000 | — | 31 Mar 2022 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.3%
|
5,025,073
|
$18,040,000 | — | 31 Mar 2022 | |
| Neuberger Berman Group LLC |
13F
|
Company |
1%
|
3,951,995
|
$14,219,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
3,916,832
|
$14,061,000 | — | 31 Mar 2022 | |
| NEEDHAM INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.98%
|
3,778,338
|
$13,565,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.77%
|
2,960,031
|
$10,627,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
2,302,278
|
$8,265,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.42%
|
1,599,180
|
$5,869,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.4%
|
1,538,106
|
$5,522,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
1,338,756
|
$4,806,000 | — | 31 Mar 2022 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.25%
|
980,505
|
$3,520,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
970,570
|
$3,485,000 | — | 31 Mar 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.22%
|
850,000
|
$3,052,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
830,029
|
$2,980,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
732,312
|
$2,628,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
694,491
|
$2,493,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
687,046
|
$2,467,000 | — | 31 Mar 2022 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
400,288
|
$1,437,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
280,186
|
$1,006,000 | — | 31 Mar 2022 | |
| Stephen Christopher Linthwaite |
3/4/5
|
President & CEO |
—
mixed-class rows
|
390,252
mixed-class rows
|
$1,004,213 | — | 22 Feb 2022 | |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
200,000
|
$718,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
197,153
|
$708,000 | — | 31 Mar 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.05%
|
190,388
|
$683,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
171,800
|
$617,000 | — | 31 Mar 2022 | |
| Employees Retirement System of Texas |
13F
|
Company |
0.04%
|
165,000
|
$592,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
159,261
|
$572,000 | — | 31 Mar 2022 | |
| Nicolas Barthelemy |
3/4/5
|
Director |
—
class O/S missing
|
204,077
|
$518,356 | — | 01 Apr 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
117,500
|
$422,000 | — | 31 Mar 2022 | |
| Gerhard F. Burbach |
3/4/5
|
Director |
—
mixed-class rows
|
139,398
mixed-class rows
|
$405,157 | — | 15 Jun 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.03%
|
113,030
|
$405,000 | — | 31 Mar 2022 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.03%
|
108,368
|
$389,000 | — | 31 Mar 2022 | |
| Bradley Allen Kreger |
3/4/5
|
SVP, Global Operations |
—
mixed-class rows
|
147,741
mixed-class rows
|
$381,265 | — | 20 May 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.03%
|
105,039
|
$377,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
98,000
|
$352,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
96,549
|
$347,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
96,009
|
$345,000 | — | 31 Mar 2022 | |
| Nicholas Khadder |
3/4/5
|
SVP, Gen. Counsel & Secretary |
—
mixed-class rows
|
130,021
mixed-class rows
|
$336,457 | — | 31 May 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
93,606
|
$336,000 | — | 31 Mar 2022 | |
| Bill Colston |
3/4/5
|
Director |
—
mixed-class rows
|
101,859
mixed-class rows
|
$309,808 | — | 15 Jun 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.02%
|
82,974
|
$297,876 | — | 31 Mar 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
73,744
|
$265,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
70,300
|
$252,000 | — | 31 Mar 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
68,384
|
$245,000 | — | 31 Mar 2022 | |
| Michael F. Price |
13F
|
Individual |
0.02%
|
65,000
|
$233,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
64,916
|
$233,000 | — | 31 Mar 2022 | |
| Colin McCracken |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
78,092
mixed-class rows
|
$201,082 | — | 22 Feb 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
54,992
|
$197,000 | — | 31 Mar 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.01%
|
53,790
|
$193,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
52,365
|
$188,000 | — | 31 Mar 2022 |
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2022
As of 30 Jun 2022,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,847,181 shares.
The largest 10 holders included
Indaba Capital Management, L.P., PRIMECAP MANAGEMENT CO/CA/, Neuberger Berman Group LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., and MILLENNIUM MANAGEMENT LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
103
Q2 2022 holders
78
Holder diff
-25
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.